California Form 61-211: Drug PA and Step Therapy

California prescribers send this four-page form to a health plan, insurer or delegated medical group to request prior authorization of a prescription drug or an exception to step therapy. The Department of Managed Health Care and the Department of Insurance developed it as a mandatory form under SB 282 and AB 374 (2015). A plan that does not respond within 72 hours, or 24 hours in exigent circumstances, is deemed to grant the request.

Who completes it

The prescriber, or office staff listed as the requester, completes the patient, insurance, prescriber, medication and clinical sections, and the prescriber signs the attestation on page 4. The plan, insurer or medical group fills in only its own name and fax at the top and the Plan/Insurer Use Only box.

How to fill it in

Plan/Medical Group Name, Phone and Fax; Non-Urgent or Exigent Circumstances

Enter the health plan, insurer or delegated medical group that will decide the request, with its phone and fax, unless a plan-issued copy already has them filled in. Check Non-Urgent or Exigent Circumstances. The box sets which response clock applies: 72 hours for a non-urgent request or 24 hours for an exigent one, after which an unanswered request is deemed granted.

Patient Information

Give the patient's first and last name, middle initial, phone, address, date of birth, sex, height, weight and allergies. If someone is acting for the patient, add the authorized representative's name and phone number. The form notes that the information on it is protected health information under HIPAA, and page 3 repeats the patient name and ID.

Insurance Information

List the primary insurance name with the patient's ID number, and any secondary insurance with its own ID number. The plan uses this to match the request to the member's coverage, and a renewal also asks which insurer paid for the drug before.

Prescriber Information

Enter the prescriber's name, specialty and address, the requester if someone other than the prescriber is sending it, an office contact person, phone, a fax number in a HIPAA-compliant area, and email. The individual NPI is requested and the form marks the DEA number as required. The plan's reply and any request for more information come back to these contacts.

Medication / Medical and Dispensing Information

Name the medication and check New Therapy, Renewal or Step Therapy Exception Request. For a renewal, give the date therapy started and its duration, and say how the patient received the drug: paid under which insurance, the prior authorization number if known, or other. Add dose and strength, frequency, quantity, length of therapy and refills, the route (oral or sublingual, topical, injection, IV, other) and where it is given, from physician's office or infusion center to home or long-term care.

1. Has the patient tried any other medication for this condition?

Answer yes or no. If yes, list each drug and dosage tried, the dates of therapy and the response, reason for failure or allergy. This is the core of a step therapy exception and of many prior authorization criteria, so give specific dates and outcomes rather than a general statement that other drugs failed.

2. List Diagnoses (ICD-10)

List the diagnoses that support the request with their ICD-10 codes. Include every diagnosis the clinical justification in question 3 relies on, such as a condition that makes the plan's preferred drug contraindicated, so the reviewer sees the coded diagnosis next to the reasoning.

3. Clinical information and Attachments

Describe symptoms, lab results with dates and the justification for starting therapy, continuing it or increasing the dose, and note any contraindication to the plan's preferred drug. Labs with dates are required when needed to establish the diagnosis or evaluate response. Add any other clinical facts, including the exigent circumstances behind an urgent request or information required under state and federal law, and list the attached chart notes or lab reports.

Attestation and Prescriber Signature (page 4)

The prescriber attests that the information is true and accurate and acknowledges that the plan, insurer, medical group or its designees may audit and request records to verify it. Sign by hand or with electronic ID verification and date it. Leave the Plan/Insurer Use Only box, where the plan records receipt and decision times, approval or denial and any information requested, blank.

Common mistakes

  • Leaving applicable sections blank or illegible; the instructions ask for every applicable section on the form to be filled out completely and legibly.
  • Sending the form without chart notes or lab data, or without dated lab results when they are needed to establish the diagnosis or evaluate the response to therapy.
  • Omitting the DEA number, which the form marks as required, or giving a group NPI where the form asks for the prescriber's individual NPI.
  • For a step therapy exception, failing to list the drugs already tried with dosage, dates and the reason for failure or allergy in question 1.
  • Checking Exigent Circumstances without explaining the exigency in the clinical information, or forgetting to check it when the faster 24-hour review is needed.

Submitting and payment

How to submit it
Fax it or submit it electronically to the health plan, insurer or delegated medical group named at the top, with chart notes or lab data attached. The plan has 72 hours to respond, or 24 hours when exigent circumstances apply, before the request is deemed granted.

Good to know

  • The state version is footed Revised 12/16 Form 61-211. Many plans repost it with their own name and fax prefilled, sometimes with a later revision date, so practices see several copies.
  • Requests left unanswered past 72 hours, or 24 hours when exigent circumstances apply, are deemed granted under Health and Safety Code 1367.241 and Insurance Code 10123.191.
  • DMHC says providers should submit the justification and clinical documentation supporting their determination as described in Health and Safety Code section 1367.206, so attach the records the plan needs to decide.
  • Renewal requests ask for the date therapy began and how the patient has been getting the drug, including the insurer that paid and any earlier prior authorization number.

Get the official form

Download the current version from the source each time; forms change without notice.

Prescription Drug Prior Authorization or Step Therapy Exception Request Form

How this list is checked

A form is listed only after its name and number were confirmed on the issuing agency’s or insurer’s own website, or in the form itself. Each entry links to that source. The list was last checked in October 2026. Forms and their requirements change without notice, so check the official page for the current version before you complete one.

Vero is not affiliated with, or endorsed by, the agencies and insurers listed here. Read our editorial policy.

Frequently asked questions

Do California health plans have to accept Form 61-211?

Form 61-211 is the mandatory prescription drug prior authorization and step therapy exception form that DMHC and the Department of Insurance developed under SB 282 and AB 374 (2015), and providers use it for these requests. Plans, insurers and delegated medical groups often repost it with their own name and fax number already filled in.

How long does a plan have to respond to Form 61-211?

72 hours for a non-urgent request and 24 hours when exigent circumstances apply. If the plan, insurer or medical group does not respond in time, the request is deemed granted. Check the Non-Urgent or Exigent Circumstances box at the top of page 1 and explain any exigency in the clinical information on page 3.

Can Form 61-211 be used for a step therapy exception?

Yes. The medication section has a Step Therapy Exception Request box next to New Therapy and Renewal. For an exception, question 1 on page 3 is the key part: list each drug already tried with its dose, the dates of therapy and the response, reason for failure or allergy, and note any contraindication to the plan's preferred drug.

What should I attach to Form 61-211?

The instructions ask for any documentation important to the review, such as chart notes or lab data. Lab results with dates must be provided when they are needed to establish the diagnosis or evaluate response. Attachments are listed at the end of the clinical section on page 3 before the prescriber signs the attestation on page 4.